1. AB0985 Methotrexate as induction of remission therapy for localized manifestations of IGG4-related disease. (15th June 2017) Authors: Rovati, L; Della-Torre, E; Lanzillotta, M; Cassione, E Bozzalla; Bozzolo, E; Canevari, C; Falconi, M; Dagna, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of biological agents in adult-onset Still's disease. (July 2015) Authors: Cavalli, G; Franchini, S; Aiello, P; Guglielmi, B; Berti, A; Campochiaro, C; Sabbadini, MG; Baldissera, E; Dagna, L Journal: Scandinavian journal of rheumatology Issue: Volume 44:Number 4(2015) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of interleukin-1 blockade with anakinra in the management of post-COVID-19 steroid-dependent multisystem inflammatory syndrome: a case report. (4th March 2023) Authors: Rinaldi, E; Tomelleri, A; Campochiaro, C; Dagna, L Journal: Scandinavian journal of rheumatology Issue: Volume 52:Number 2(2023) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0325 Prevalence of takayasu arteritis in young women with acute ischemic heart disease. (15th June 2017) Authors: Cavalli, G; Tomelleri, A; Baldissera, E; Dagna, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment. Issue 2 (12th January 2009) Authors: Di Comite, G; Previtali, P; Rossi, C M; Dell'Antonio, G; Rovere-Querini, P; Praderio, L; Dagna, L; Corti, A; Doglioni, C; Maseri, A; Sabbadini, M G; Manfredi, A A Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 2(2009) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. (3rd March 2016) Authors: Campochiaro, C; Ramirez, GA; Bozzolo, EP; Lanzillotta, M; Berti, A; Baldissera, E; Dagna, L; Praderio, L; Scotti, R; Tresoldi, M; Roveri, L; Mariani, A; Balzano, G; Castoldi, R; Doglioni, C; Sabbadini, MG; Della-Torre, E Journal: Scandinavian journal of rheumatology Issue: Volume 45:Number 2(2016) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy. (4th May 2022) Authors: Campochiaro, C; Tomelleri, A; Farina, N; Cavalli, G; De Luca, G; Palmisano, A; Peretto, G; Esposito, A; Rizzo, S; Basso, C; Matucci-Cerinic, M; Dagna, L Journal: Scandinavian journal of rheumatology Issue: Volume 51:Number 3(2022) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP0092 Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration and improves exercise tolerance. (15th June 2017) Authors: Cavalli, G; Ballak, D; Justice, JJ; Boyle, K; D'Alessandro, A; Joosten, LA; Dagna, L; Dinarello, CA Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0179 Brafv600e promotes myeloid skewing in multisystemic langerhans cell histiocytosis humanized mouse model. (15th June 2017) Authors: Biavasco, R; Norelli, M; Camisa, B; Cesana, D; Gallina, P; Gentner, B; Ponzoni, M; Dagna, L; Bondanza, A; Montini, E Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P087 The anti-inflammatory cytokine interleukin 37 is an endogenous inhibitor of trained immunity. (March 2019) Authors: Cavalli, G; Gresnigt, M; Nemkov, T; Arts, R; D'Alessandro, A; Giugliano, S; Eisenmensser, E; Dagna, L; Joosten, L; Netea, M; Dinarello, C Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗